Natco Pharma Q2 net profit falls 60.8% to ₹202.6 crore
In short
Natco Pharma said on Friday that its consolidated net profit fell 60.8% to ₹202.6 crore in the September quarter.
Revenue from operations dropped to ₹967.3 crore from ₹1,363 crore a year earlier, and total expenses came down to ₹776.2 crore. The company also bought an extra 13.25% stake during the quarter.
What the reporting says
Natco Pharma on Friday reported a 60.8% drop in consolidated net profit to ₹202.6 crore for the September quarter, according to a regulatory filing. Revenue from operations fell to ₹967.3 crore from ₹1,363 crore a year earlier, while total expenses declined to ₹776.2 crore from ₹849.3 crore. The company also said it acquired an additional 13.25% stake during the quarter.
Why it matters
Natco Pharma reported a sharp fall in September-quarter profit and revenue in a regulatory filing. Net profit dropped to ₹202.6 crore from ₹517.9 crore a year ago, while revenue from operations fell to ₹967.3 crore. Total expenses also declined. The filing additionally said the company acquired an extra 13.25% stake during the quarter, which may be relevant for investors tracking ownership changes and operating performance.